• 1. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 2. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 3. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 4. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Straight chain fatty acids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Straight chain fatty acids

5-Amino-5-oxopentanoic Acid (CAS No. 25335-74-4): A Comprehensive Overview

5-Amino-5-oxopentanoic acid (CAS No. 25335-74-4) is a versatile organic compound that has garnered significant attention in the fields of chemistry, biochemistry, and pharmaceutical research. This compound, also known as aminolevulinic acid (ALA), plays a crucial role in various biological processes and has been extensively studied for its potential therapeutic applications.

The chemical structure of 5-Amino-5-oxopentanoic acid consists of a five-carbon backbone with an amino group and a carboxylic acid group, making it a key intermediate in the biosynthesis of porphyrins, which are essential components of hemoglobin and chlorophyll. The compound's unique properties have led to its exploration in multiple areas, including drug development, medical diagnostics, and biotechnological applications.

In recent years, the research on 5-Amino-5-oxopentanoic acid has expanded significantly, driven by its potential as a prodrug and its ability to enhance the production of protoporphyrin IX (PpIX). PpIX is a photosensitizer that can be used in photodynamic therapy (PDT) for the treatment of various cancers and skin conditions. Studies have shown that when administered topically or systemically, 5-Amino-5-oxopentanoic acid can effectively increase PpIX levels in target tissues, thereby enhancing the efficacy of PDT.

Beyond its applications in PDT, 5-Amino-5-oxopentanoic acid has also been investigated for its neuroprotective properties. Research suggests that this compound can reduce oxidative stress and inflammation in neuronal cells, making it a promising candidate for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Additionally, studies have explored the use of 5-Amino-5-oxopentanoic acid in combination with other therapeutic agents to enhance their effectiveness.

The pharmacokinetic properties of 5-Amino-5-oxopentanoic acid have been extensively studied to optimize its delivery and bioavailability. Research has shown that the compound can be administered via various routes, including oral, intravenous, and topical application. The choice of administration route depends on the specific therapeutic application and the desired tissue penetration. For instance, topical application is often preferred for skin conditions, while systemic administration is more suitable for internal cancers.

In the realm of drug development, 5-Amino-5-oxopentanoic acid has been used as a precursor for the synthesis of more complex molecules with enhanced therapeutic properties. Derivatives of ALA have been designed to improve solubility, stability, and targeting capabilities. These derivatives have shown promise in preclinical studies and are currently being evaluated in clinical trials for their safety and efficacy.

The safety profile of 5-Amino-5-oxopentanoic acid is another important aspect that has been thoroughly investigated. Clinical trials have demonstrated that the compound is generally well-tolerated with minimal side effects when used at appropriate doses. However, like any therapeutic agent, it is essential to monitor patients for potential adverse reactions and adjust dosing as necessary.

In conclusion, 5-Amino-5-oxopentanoic acid (CAS No. 25335-74-4) is a multifaceted compound with a wide range of applications in medicine and biotechnology. Its role in photodynamic therapy, neuroprotection, and drug development highlights its potential to address various medical challenges. Ongoing research continues to uncover new insights into the mechanisms of action and therapeutic potential of this versatile compound.

• 638-32-4(Succinamic acid)
• 61798-00-3(Nonanoic acid,9-amino-9-oxo-)
• 334-25-8(5-carbamoylpentanoic acid)
• 181289-15-6(3-Carbamoymethyl-5-methylhexanoic acid)
• 52235-79-7(hexanedioic acid - undecane-1,11-diamine (1:1))
• 6422-99-7(sebacic acid, compound with hexane-1,6-diamine (1:1))
• 38775-37-0(azelaic acid, compound with hexane-1,6-diamine (1:1))
• 181289-33-8((R)-(-)-3-(Carbamoylmethyl)-5-methylhexanoic acid)
• 181289-34-9(Hexanoicacid, 3-(2-amino-2-oxoethyl)-5-methyl-, (3S)-)
• 32850-57-0(decan-1-aminium dodecanoate)